Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 2724986)

Published in Am J Transplant on May 13, 2009

Authors

L Li1, A Chang, M Naesens, N Kambham, J Waskerwitz, J Martin, C Wong, S Alexander, P Grimm, W Concepcion, O Salvatierra, M M Sarwal

Author Affiliations

1: Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

Associated clinical trials:

Steroid Withdrawal in Pediatric Kidney Transplant Recipients | NCT00023244

Articles citing this

Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50

Growth of kidney-transplanted pediatric patients treated with sirolimus. Pediatr Nephrol (2011) 1.46

Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up. Am J Transplant (2012) 1.45

Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation. Am J Transplant (2012) 1.18

Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol (2009) 0.99

The clinical impact of humoral immunity in pediatric renal transplantation. J Am Soc Nephrol (2013) 0.89

Steroid withdrawal in renal transplantation. Pediatr Nephrol (2013) 0.84

Effects of steroid avoidance and novel protocols on growth in paediatric renal transplant patients. Pediatr Nephrol (2009) 0.82

Early steroid withdrawal in pediatric renal transplant: five years of follow-up. Pediatr Nephrol (2011) 0.82

Reliable individualized monitoring improves cholesterol control in kidney transplant recipients. Pediatrics (2013) 0.81

Longitudinal relations between obesity and hypertension following pediatric renal transplantation. Pediatr Nephrol (2010) 0.81

Final adult height in kidney recipients who underwent highly successful transplantation as children: a single-center experience. Clin Exp Nephrol (2013) 0.79

New-onset diabetes after kidney transplant in children. Pediatr Nephrol (2014) 0.76

Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy. Transplantation (2016) 0.75

Hypomagnesemia and increased risk of new-onset diabetes mellitus after transplantation in pediatric renal transplant recipients. Pediatr Nephrol (2016) 0.75

Long-term effects of paediatric kidney transplantation. Nat Rev Nephrol (2015) 0.75

Renal transplantation in infants. Pediatr Nephrol (2015) 0.75

Articles cited by this

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med (1994) 4.22

A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr (1985) 3.35

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant (2008) 2.81

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation (1995) 2.67

A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr (1984) 2.31

Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years. Transplantation (2006) 1.81

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med (1993) 1.80

Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant (2006) 1.66

Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression. Pediatr Transplant (2003) 1.48

Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation (1998) 1.47

Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol (1983) 1.43

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation (2005) 1.39

A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol (2000) 1.35

Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group. Transplantation (1999) 1.29

Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. Am J Transplant (2004) 1.26

Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation (2003) 1.23

Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation (2001) 1.19

Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant (2005) 1.17

Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol (1993) 1.17

Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int (2002) 1.14

Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation (2004) 1.13

A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. Am J Transplant (2005) 1.09

A typology of non-adherence in pediatric renal transplant recipients. Pediatr Transplant (2003) 1.06

FK 506 versus cyclosporine. Transplant Proc (1993) 1.03

Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood (2005) 0.99

Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant (2004) 0.97

Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant (2007) 0.97

The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant (2007) 0.97

Corticosteroid avoidance in pediatric renal transplantation. Pediatr Nephrol (2005) 0.96

An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin Transplant (1999) 0.95

Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant (2005) 0.94

A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc (2005) 0.92

Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation (2004) 0.90

Avoidance of chronic steroid therapy in african american kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant (2005) 0.89

Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. Transplantation (2008) 0.88

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation (2001) 0.87

Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. Clin Transplant (2006) 0.86

Bone loss after glucocorticoid therapy. Calcif Tissue Int (1984) 0.86

Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation (2007) 0.85

Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients. Transplantation (2001) 0.85

Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs. Pediatr Transplant (2007) 0.85

Steroid withdrawal in pediatric and adult renal transplant recipients. Pediatr Nephrol (2005) 0.80

A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant (2000) 0.78

Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity. Transplant Proc (1993) 0.77

Four decades of glucocorticosteroid immunosuppression. CMAJ (1993) 0.77

Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction. Transplant Proc (2006) 0.76

Articles by these authors

The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord (2001) 14.30

Mutation of human short tandem repeats. Hum Mol Genet (1993) 14.03

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell (1988) 10.29

Rates and implications of caesarean sections in Latin America: ecological study. BMJ (1999) 9.86

Immunogenic structure of the influenza virus hemagglutinin. Cell (1982) 8.93

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55

Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (1997) 8.24

Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol (1995) 7.86

Junior doctors' hours. Members of Junior Doctors Committee are in cloud cuckoo land. BMJ (1995) 7.84

endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins. Proc Natl Acad Sci U S A (1982) 6.64

Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01

Fast and fuel efficient? Optimal use of wind by flying albatrosses. Proc Biol Sci (2000) 5.73

Customised antenatal growth charts. Lancet (1992) 5.34

Mitochondrial heat-shock protein hsp60 is essential for assembly of proteins imported into yeast mitochondria. Nature (1989) 5.19

Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82

Testing technical skill via an innovative "bench station" examination. Am J Surg (1997) 4.75

Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med (2001) 4.67

The Human Connectome Project: a data acquisition perspective. Neuroimage (2012) 4.64

Optical coherence tomography of macular holes. Ophthalmology (1995) 4.64

Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med (1992) 4.54

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J (1997) 4.53

A study of the quality of life and cost-utility of renal transplantation. Kidney Int (1996) 4.51

Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol (1995) 4.47

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol (2001) 4.06

Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain (2005) 3.99

Toward a molecular genetic analysis of spermatogenesis in Drosophila melanogaster: characterization of male-sterile mutants generated by single P element mutagenesis. Genetics (1993) 3.75

An adjustable fetal weight standard. Ultrasound Obstet Gynecol (1995) 3.70

A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet (2000) 3.63

In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun (1995) 3.56

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest (1987) 3.29

Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29

Demonstration of peptide:N-glycosidase F activity in endo-beta-N-acetylglucosaminidase F preparations. J Biol Chem (1984) 3.26

Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J (1982) 3.23

Energy saving in flight formation. Nature (2001) 3.17

Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet (1996) 3.02

Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol (1996) 2.98

Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development (1999) 2.89

The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am (1993) 2.85

Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 2.80

Randomised controlled trial of routine cervical examinations in pregnancy. European Community Collaborative Study Group on Prenatal Screening. Lancet (1994) 2.74

Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol (1996) 2.71

What is the optimal age for starting lipid lowering treatment? A mathematical model. BMJ (2000) 2.65

Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet (1995) 2.62

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS (2000) 2.61

Large-scale taxonomic profiling of eukaryotic model organisms: a comparison of orthologous proteins encoded by the human, fly, nematode, and yeast genomes. Genome Res (1998) 2.60

p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev (1999) 2.58

Seasonality and the requirements for perpetuation and eradication of viruses in populations. Am J Epidemiol (1979) 2.58

Localization of ATP Sulfurylase and O-Acetylserine(thiol)lyase in Spinach Leaves. Plant Physiol (1990) 2.55

Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol (2001) 2.54

Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry (1999) 2.50

Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49

An encyclopedia of mouse genes. Nat Genet (1999) 2.48

Protein folding in the central cavity of the GroEL-GroES chaperonin complex. Nature (1996) 2.46

Consensus meeting: monosodium glutamate - an update. Eur J Clin Nutr (2006) 2.44

Treating chronic pain. Am Fam Physician (1997) 2.40

Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev (1998) 2.39

Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol (2000) 2.38

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys (1999) 2.36

Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA (2000) 2.35

Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci U S A (1998) 2.32

Protein folding in the cell: the role of molecular chaperones Hsp70 and Hsp60. Annu Rev Biophys Biomol Struct (1992) 2.31

The management of acute bronchiolitis. Thoracic Society of Australia and New Zealand. J Paediatr Child Health (1993) 2.30

Effect of a media-led education campaign on breast and cervical cancer screening among Vietnamese-American women. Prev Med (1999) 2.28

Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science (1987) 2.27

The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage (2006) 2.27

Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol (1993) 2.27

Plasma membrane proton ATPase Pma1p requires raft association for surface delivery in yeast. Mol Biol Cell (2001) 2.27

Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol (1997) 2.25

A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25

Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study. Health Technol Assess (2008) 2.24

Gamma Knife radiosurgery for treatment of trigeminal neuralgia: idiopathic and tumor related. Neurology (1997) 2.23

Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial. FECG Study Group. Lancet (2000) 2.22

Retroviral diversity and distribution in vertebrates. J Virol (1998) 2.22

Chaperonin-mediated protein folding: GroES binds to one end of the GroEL cylinder, which accommodates the protein substrate within its central cavity. EMBO J (1992) 2.20

Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol (2001) 2.20

Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19

British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax (2013) 2.17

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer (1994) 2.14

Isolation of a glucan-binding domain of glucosyltransferase (1,6-alpha-glucan synthase) from Streptococcus sobrinus. Infect Immun (1988) 2.13

Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging (1992) 2.11

Access to kidney transplantation. Has the United States eliminated income and racial differences? Arch Intern Med (1988) 2.11

Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther (1999) 2.11

Late complications after ligation and bypass for popliteal aneurysm. Br J Surg (2004) 2.07

Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. (Official report from the International Society for Peritoneal Dialysis) Perit Dial Int (1998) 2.06

Anxiety among hospitalized latency-age children. J Dev Behav Pediatr (1990) 2.06

Validation of an objective structured assessment of technical skill for surgical residents. Acad Med (1996) 2.06

Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis. Hum Genet (1990) 2.05

Hospitalization in an urban homeless population: the Honolulu Urban Homeless Project. Ann Intern Med (1992) 2.04

Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci (2001) 2.04

Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol (1995) 2.03

Thyroid function tests: often justified in the acutely ill. Ann Clin Biochem (2000) 2.03

Malaria. Nurs Stand (2002) 2.02

Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int (2001) 1.99

Is hand, foot and mouth disease associated with meteorological parameters? Epidemiol Infect (2010) 1.99

The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell (1996) 1.99

Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation (1996) 1.99